General Information
Revision date
2012-03-15
Product name
Unasyn , UNASYNA; UNACIM; UNACID; UNACIM; BEGALIN-P; DUOCID
Emergency telephone
(24 hours) 1-800-424-9300
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
WARNING
Section 2
SECTION 2: Hazards identification
Appearance: Off-white dry powder - powder may be reconstituted to a pale yellow/yellow solution
Signal word
WARNING
Hazard statements
May cause allergic skin reaction. May cause allergic or asthmatic symptoms or breathing difficulties if inhaled. May cause damage to liver through prolonged or repeated exposure.
Additional information
Short Term: Accidental ingestion may cause effects similar to those seen in clinical use. Ampicillin is reported to induce environmental or occupational asthma. Individuals who are allergic to penicillin antibiotics could have allergic reaction, possibly severe. Long Term: Repeat-dose studies in animals have shown a potential to cause adverse effects on liver. Known Clinical Effects: Adverse effects seen during clinical use are infrequent (<3%) and include diarrhea and skin rash. Pseudomembranous colitis has been reported following the use of Unasyn® EU Indication of danger: Irritant Harmful EU Hazard Symbols: EU Risk Phrases: R42/43 - May cause sensitization by inhalation and skin contact. R48/22 - Harmful: danger of serious damage to health by prolonged exposure if swallowed. Australian Hazard Classification
Hazardous Ingredients
Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.